We found a match
Your institution may have access to this item. Find your institution then sign in to continue.
- Title
Single Dose of Etanercept Injection: A Game Changer in Toxic Epidermal Necrolysis: A Case Series.
- Authors
KANNAN, RAJKUMAR; DANIEL, SAMUEL JEYARAJ; KUMAR, PARIMALAM; KAVIMANI, LAVANYA
- Abstract
Toxic Epidermal Necrolysis (TEN) is a rare hypersensitivity reaction to drugs, characterised by widespread erythema, full-thickness epidermal necrosis with mucosal involvement, and extensive apoptosis. It is a dermatological emergency and can be lethal if not promptly treated. The use of steroids in managing TEN is controversial since no gold standard therapy exists. However, a single dose of subcutaneous injection of Etanercept (a Tumour Necrosis Factor-alpha (TNF-a) inhibitor) at a dosage of 50 mg has shown promise in preventing mortality and reducing hospital stay. The authors present a case series of six TEN patients, out of which three received a single dose of Etanercept injection. All patients who received Etanercept showed a positive response, achieving complete re-epithelialisation with a median healing time of nine days. In conclusion, injection of Etanercept, a TNF-a inhibitor, effectively inhibits Fas-Fas ligand activation, thus preventing apoptosis and extensive necrosis.
- Subjects
ETANERCEPT; SUBCUTANEOUS injections; TOXIC epidermal necrolysis; DRUG side effects; INJECTIONS; STEROID drugs
- Publication
Journal of Clinical & Diagnostic Research, 2023, Vol 17, Issue 11, p1
- ISSN
0973-709X
- Publication type
Article
- DOI
10.7860/JCDR/2023/62912.18615